Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001886794-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | 2026-03-09 | PCVX | Dhaliwal Harpreet S. | Chief Technical Ops Off | F - Tax | $59.32 | -604 | 76.0K | -0.8% | -$35.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-09 | F | D | 604 | $59.32 | 75,976 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person. |